Schedule 13D ownership disclosure

Emmaus Life Sciences, Inc.

Security class unavailable · CUSIP: 29137T101

Event date: 2023-01-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
35.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-23-013201
Form type
SC 13D/A
Filer
Emmaus Life Sciences, Inc.
CIK
CIK 822370
Filed
Feb 21, 2023
Reporting period
Jan 12, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub